Cargando…
An overview of the BOIN design and its current extensions for novel early-phase oncology trials
Bayesian Optimal Interval (BOIN) designs are a class of model-assisted dose-finding designs that can be used in oncology trials to determine the maximum tolerated dose (MTD) of a study drug based on safety or the optimal biological dose (OBD) based on safety and efficacy. BOIN designs provide a comp...
Autores principales: | Ananthakrishnan, Revathi, Lin, Ruitao, He, Chunsheng, Chen, Yanping, Li, Daniel, LaValley, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260438/ https://www.ncbi.nlm.nih.gov/pubmed/35812822 http://dx.doi.org/10.1016/j.conctc.2022.100943 |
Ejemplares similares
-
Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials
por: Ananthakrishnan, Revathi, et al.
Publicado: (2018) -
Systematic comparison of the statistical operating characteristics of various Phase I oncology designs
por: Ananthakrishnan, Revathi, et al.
Publicado: (2016) -
2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy
por: Ananthakrishnan, Revathi, et al.
Publicado: (2019) -
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trials
por: Mu, Rongji, et al.
Publicado: (2021) -
4525 Estimates of Dose Response using the Dixon Up-and-Down Method and BOIN study designs
por: Minard, Charles Gene
Publicado: (2020)